Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura

World Journal of Gastroenterology

Volumn 20, Issue 22, 2014, Pages 6918-6923

  Noonavath, Ravinder Naik ^a   Lakshmi, Chandrasekharan Padma ^a   Dutta, Tarun Kumar ^a   Kate, Vikram ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Helicobacter pylori; Immune thrombocytopenic purpura; Platelet counts

Indexed keywords

AMOXICILLIN; AZATHIOPRINE; DAPSONE; LEVOFLOXACIN; OMEPRAZOLE; PREDNISOLONE; ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ERADICATION; EPISTAXIS; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GINGIVA BLEEDING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; MENORRHAGIA; PETECHIA; PREVALENCE; RAPID UREASE TEST; STOMACH BIOPSY; THROMBOCYTE COUNT; YOUNG ADULT; BIOPSY; BLOOD; CHRONIC DISEASE; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; GASTROSCOPY; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TIME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BIOPSY; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PLATELET COUNT; PROTON PUMP INHIBITORS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902172719     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i22.6918     Document Type: Article

References (23)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315 [PMID: 6145023 DOI: 10.1016/S0140-673 6(84)91816-6]
2. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878 [PMID: 9742983 DOI: 10.1016/S0140-6736(05)60004-9]
3. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001; 97: 812-814 [PMID: 11157503 DOI: 10.1182/blood.V97.3.812]
4. Suzuki H, Marshall BJ, Hibi T. Overview: Helicobacter pylori and extragastric disease. Int J Hematol 2006; 84: 291-300 [PMID: 17118754 DOI: 10.1532/IJH97.06180]
5. Menaker RJ, Sharaf AA, Jones NL. Helicobacter pylori infection and gastric cancer: host, bug, environment, or all three? Curr Gastroenterol Rep 2004; 6: 429-435 [PMID: 15527671 DOI: 10.1007/s11894-004-0063-9]
6. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda K, Nomura S, Sugihara S, Shimomura T, Fujimoto TT, Oyashiki K, Ikeda Y. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005; 81: 162-168 [PMID: 15765787 DOI: 10.1532/IJH97.04146]
7. Inaba T, Mizuno M, Take S, Suwaki K, Honda T, Kawai K, Fujita M, Tamura T, Yokota K, Oguma K, Okada H, Shiratori Y. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005; 35: 214-219 [PMID: 15733077 DOI: 10.1111/j.1365-2362.2005.01471.x]
8. Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, Ohtsuka E, Kodama M, Saburi Y, Fujioka T, Nasu M. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004; 164: 1904-1907 [PMID: 15451766 DOI: 10.1001/archinte.164.17.1904]
9. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004; 124: 91-96 [PMID: 14675413 DOI: 10.1046/j.1365-2141.2003.04735.x]
10. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004; 103: 890-896 [PMID: 12920031 DOI: 10.1182/blood-2003-03-0900]
11. Ahn ER, Tiede MP, Jy W, Bidot CJ, Fontana V, Ahn YS. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts. Acta Haematol 2006; 116: 19-24 [PMID: 16809885 DOI: 10.1159/000092343]
12. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-2393 [PMID: 19005182 DOI: 10.1182/ blood-2008-07-162503]
13. Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 2005; 100: 1265-1270 [PMID: 15929755 DOI: 10.1111/ j.1572-0241.2005.41641.x]
14. Jones VS, Kate V, Ananthakrishnan N, Badrinath S, Amarnath SK, Ratnakar C. Standardization of urease test for detection of Helicobacter pylori. Indian J Med Microbiol 1997; 15: 181-183
15. Hershko C, Ianculovich M, Souroujon M. A hematologist's view of unexplained iron deficiency anemia in males: impact of Helicobacter pylori eradication. Blood Cells Mol Dis 2007; 38: 45-53 [PMID: 17067833 DOI: 10.1016/j.bcmd.2006.09.006]
16. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, Volzone F, Jovic G, Leonardi G, Donelli A, Torelli G. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007; 110: 3833-3841 [PMID: 17652264 DOI: 10.1182/blood-2006-12-063222]
17. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005; 118: 414-419 [PMID: 15808140 DOI: 10.1016/ j.amjmed.2004.09.014]
18. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, Cho SH, Oh BH. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007; 12: 333-340 [PMID: 17669107 DOI: 10.1111/j.1523-5378.2007.00504. x]
19. Russo A, Eboli M, Pizzetti P, Di Felice G, Ravagnani F, Spinelli P, Hotz AM, Notti P, Maconi G, Franceschi S, Ferrari D, Bertario L. Determinants of Helicobacter pylori seroprevalence among Italian blood donors. Eur J Gastroenterol Hepatol 1999; 11: 867-873 [PMID: 10514119 DOI: 10.1097/00042737-1 99908000-00010]
20. Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B, Bierling P. Autoimmune thrombocytopenic Purpura and Helicobacter pylori infection. Arch Intern Med 2002; 162: 1033-1036 [PMID: 11996614 DOI: 10.1001/archinte.162.9.1033]
21. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-1501 [PMID: 2019355]
22. Fraser AG, Scragg R, Metcalf P, McCullough S, Yeates NJ. Prevalence of Helicobacter pylori infection in different ethnic groups in New Zealand children and adults. Aust N Z J Med 1996; 26: 646-651 [PMID: 8958359 DOI: 10.1111/j.1445-5994.1996. tb02934.x]
23. Malaty HM, Graham DY, Wattigney WA, Srinivasan SR, Osato M, Berenson GS. Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community. Clin Infect Dis 1999; 28: 279-282 [PMID: 10064244 DOI: 10.1086/515105]